1-3 of 3
Mary Ellen Rybak
Close
Sort by
Journal Articles

In Vivo Depletion of Cynomolgus Monkey B Cells Targeted by a Novel Monoclonal Antibody (Xi-20H5) Specific for a Shared Portion of the Human Immunoglobulin Variable Light Chain Lambda 1.

Thierry Sornasse, PhD, Keri Tate, PhD, Kimberly Milner, BS, Thomas Theriault, PhD, Dan W. Denney, Jr., PhD, (Intr. by Mary Ellen Rybak)
Journal: Blood
Blood (2007) 110 (11): 2354.
https://doi.org/10.1182/blood.V110.11.2354.2354
Published: 2007
Journal Articles

Tipifarnib (Zarnestra, R115777) as Maintenance Therapy for Adults in Complete Remission (CR) Following Induction and Consolidation Therapies for Poor-Risk Acute Myelogenous Leukemia (AML): A Phase II Trial.

Judith E. Karp, MD, Ivana Gojo, MD, Jacqueline Greer, R.N., B. Douglas Smith, MD, Maureen Klein, R.N., Jeffery E. Lancet, MD, Steven D. Gore, MD, Lawrence Morris, MD, Alain Thibault, MD, Mary Ellen Rybak, MD, John J. Wright, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2783.
https://doi.org/10.1182/blood.V106.11.2783.2783
Published: 2005
Journal Articles

Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

Clinical Trials & Observations
Judith E. Karp, Jeffrey E. Lancet, Scott H. Kaufmann, David W. End, John J. Wright, Kees Bol, Ivan Horak, Michael L. Tidwell, Jane Liesveld, Timothy J. Kottke, Dawn Ange, Laxmi Buddharaju, Ivana Gojo, W. Edward Highsmith, Robert T. Belly, Raymond J. Hohl, Mary Ellen Rybak, Alain Thibault, Joseph Rosenblatt
Journal: Blood
Blood (2001) 97 (11): 3361–3369.
https://doi.org/10.1182/blood.V97.11.3361
Published: 2001